SMEG · FACILITY RISK INTELLIGENCE

Therapy Documentation Pre-Audit Brief

Sample Skilled Nursing Facility · fictional PT, OT, and SLP excerpts · prepared to demonstrate the format facility leadership could receive after qualified human QA.

Read this first: This brief is an editorial demonstration built from SMEG-supplied synthetic information. It is not a live upload, real facility review, calibrated performance result, clinical validation claim, billing decision, medical-necessity determination, compliance certification, or outcome guarantee.
Medicare context

Part A and Part B stay separate

Context required

The applicable payer, benefit, service setting, discipline, note type, and episode must be confirmed before selecting review logic.

Human authority

Rule findings stay preliminary

QA required

Qualified reviewers confirm, modify, dismiss, or escalate prompts before anything is presented as a facility finding.

Official record

The chart remains source of truth

Facility controlled

Facility clinicians and authorized leaders retain clinical, billing, MDS, compliance, legal, and payer-policy decisions.

Illustrative review priorities

1
Daily note excerpt · PT

Review whether skilled reasoning and functional carryover are clear

The synthetic excerpt includes range-of-motion measures but only a brief statement of tolerance. A reviewer could compare the complete note with the active plan of care and determine whether resident-specific skilled decision-making and functional relevance are adequately explained.

Review prompt
2
Initial evaluation excerpt · Part B OT

Do not apply PDPM or Section GG requirements without applicable context

The synthetic excerpt is labeled Part B OT. PDPM classification and Section GG alignment are therefore not treated as required findings. The reviewer may instead examine occupational profile, baseline function, measurable goals, plan-of-care support, and applicable certification context in the complete official record.

Part B boundary
3
Daily note excerpt · SLP

Recognize evidence that is already present

The synthetic excerpt documents 0/10 overt signs during nectar-thick liquid trials. Trial counts are present and must not be flagged as missing. A reviewer may still consider whether cueing, strategy selection, and clinical response are sufficiently clear for the applicable payer and plan of care.

Trial count found
4
Supervision and signature context

Avoid blanket missing-cosignature conclusions

Whether a signature, cosignature, or supervision record is required depends on clinician credential, jurisdiction, payer, service setting, facility policy, note type, and the complete record. If those inputs are unavailable, the correct public-demo status is “not evaluated,” not “missing.”

Not evaluated
Facility decision boundary: SMEG supports clinician-led, rule-based documentation-risk review. It does not replace the EHR, authorize billing, determine payment or medical necessity, certify compliance, provide legal advice, promise survey results, guarantee reimbursement, or prevent denials. Actual records require written facility authorization and complete applicable BAA, vendor, security, access, intake, retention, deletion, and qualified-human-validation approvals. A BAA alone is insufficient.